Production (Stage)
Coeptis Therapeutics Holdings, Inc.
COEP
$8.23
-$0.13-1.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 700.98% | -53.15% | -26.85% | 51.10% | -29.94% |
| Total Receivables | -- | -- | -- | 75.97% | 178.46% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.20% | 128.17% | -7.19% | 1.16% | 0.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 342.40% | -22.96% | -31.45% | 44.29% | -21.14% |
|
|
|||||
| Total Current Assets | 342.40% | -22.96% | -31.45% | 44.29% | -21.14% |
| Net Property, Plant & Equipment | -14.39% | -12.47% | -10.89% | -9.55% | -8.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.34% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.09% | -14.60% | -14.05% | -12.32% | -10.97% |
| Total Assets | 51.01% | -0.53% | 113.32% | 7.81% | -14.81% |
|
|
|||||
| Total Accounts Payable | -11.74% | 11.96% | -11.47% | -6.20% | -3.79% |
| Total Accrued Expenses | -18.25% | -0.71% | -3.74% | 7.23% | 29.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 52.12% | -21.33% | -0.62% | -29.01% | 118.81% |
| Total Finance Division Other Current Liabilities | 61.19% | -- | -- | -- | -- |
| Total Other Current Liabilities | 61.19% | -- | -- | -- | -- |
| Total Current Liabilities | 25.23% | 31.19% | -5.11% | -15.71% | 43.92% |
|
|
|||||
| Total Current Liabilities | 25.23% | 31.19% | -5.11% | -15.71% | 43.92% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | -69.12% | 0.00% | 0.00% | 0.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -52.94% | 11.55% | -52.04% | 28.56% | -6.26% |
| Total Liabilities | 18.82% | 26.87% | -11.86% | -10.46% | 34.01% |
|
|
|||||
| Common Stock & APIC | 5.25% | 0.81% | 1.64% | 6.11% | 3.32% |
| Retained Earnings | -3.48% | -3.16% | -1.96% | -3.36% | -3.44% |
| Treasury Stock & Other | 83.95% | 25.80% | 72.19% | -37.27% | -57.14% |
| Total Common Equity | 103.40% | -33.98% | 1,190.08% | 61.20% | -240.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.40% | -33.98% | 1,190.08% | 61.20% | -240.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 44.30% | 332.53% | 19.02% | -- | -- |
| Total Equity | 92.98% | -22.38% | 1,706.71% | 72.81% | -240.12% |
|
|
|||||